The LGI1 protein: molecular structure, physiological functions and disruption-related seizures

P Baudin, L Cousyn, V Navarro - Cellular and Molecular Life Sciences, 2022 - Springer
Abstract Leucine-rich, glioma inactivated 1 (LGI1) is a secreted glycoprotein, mainly
expressed in the brain, and involved in central nervous system development and …

Patient-derived antibodies reveal the subcellular distribution and heterogeneous interactome of LGI1

J Ramirez-Franco, K Debreux, J Extremet, Y Maulet… - Brain, 2022 - academic.oup.com
Autoantibodies against leucine-rich glioma-inactivated 1 (LGI1) occur in patients with
encephalitis who present with frequent focal seizures and a pattern of amnesia consistent …

Autosomal dominant lateral temporal epilepsy in a family exhibiting a rare heterozygous mutation and deletion in the leucine-rich glioma inactivated 1 gene

J Liu, D Hu, Z Zhang, F Tang, Y Yan, Y Ma - Neuroscience Letters, 2022 - Elsevier
Autosomal dominant lateral temporal epilepsy (ADLTE) is an inherited syndrome caused by
mutations in the leucine-rich glioma inactivated 1 (LGI1) gene. In a family with six ADLTE …

Patient-derived recombinant autoantibodies reveal the subcellular neuroglial distribution and heterogeneous interactome of leucine-rich glioma-inactivated 1

J Ramirez-Franco, K Debreux, J Extremet, Y Maulet… - bioRxiv, 2022 - biorxiv.org
Autoantibodies against leucine-rich glioma-inactivated 1 (LGI1) occur in patients with
encephalitis who present with frequent focal seizures and a pattern of amnesia consistent …